Cargando…
Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?
BACKGROUND: Many smoking-cessation programs and pharmaceutical aids demonstrate substantial health gains for a relatively low allocation of resources. Genetic information represents a type of individualized or personal feedback regarding the risk of developing lung cancer, and hence the potential be...
Autores principales: | Gordon, Louisa G, Hirst, Nicholas G, Young, Robert P, Brown, Paul M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949618/ https://www.ncbi.nlm.nih.gov/pubmed/20843376 http://dx.doi.org/10.1186/1478-7547-8-18 |
Ejemplares similares
-
Does Smoking Affect OSA? What about Smoking Cessation?
por: Pataka, Athanasia, et al.
Publicado: (2022) -
Silver Spike Point Therapy in smoking cessation: What is it and does it work?
por: Al-Zalabani, Abdulmohsen H.
Publicado: (2023) -
Disparities in Receipt of Smoking Cessation Assistance Within the US
por: Maki, Kristin G., et al.
Publicado: (2022) -
Smoking cessation in community pharmacy practice–a clinical information needs analysis
por: Saba, Maya, et al.
Publicado: (2013) -
Costs of the Smoking Cessation Program in Brazil
por: Mendes, Andréa Cristina Rosa, et al.
Publicado: (2016)